Schond Greenway
Overview
Schond Greenway received an average of $2M in total compensation, including $337K in salary, at Mind Medicine (MindMed) between 2022 and 2023. Schond Greenway also received $2M at Avalo Therapeutics in 2021.
Source: SEC filings on April 26, 2024 and April 25, 2022.
Related executives
We found 21 more executives who work or worked at Mind Medicine (MindMed) and Avalo Therapeutics.
Robert Barrow
Mind Medicine (MindMed)
Chief Executive Officer
Daniel Karlin
Mind Medicine (MindMed)
Chief Medical Officer
Garry Neil
Avalo Therapeutics
Chief Executive Officer
Stephen Smolinski
Avalo Therapeutics
Former Chief Commercial Officer
Michael Cola
Avalo Therapeutics
Chief Executive Officer
Christopher Sullivan
Avalo Therapeutics
Chief Financial Officer
JR Rahn
Mind Medicine (MindMed)
Chief Executive Officer
Miri Wernli
Mind Medicine (MindMed)